诺基诺的安全性概况
Annie-Pierre Jonville-Béra1, Bérenger Largeau2, Ferderico di Meglio3
1Service de Pharmacosurveillance, Centre Régional de Pharmacovigilance Centre-Val de Loire, CHU de Tours F-37000 Tours, France; Université de Tours, Université de Nantes, INSERM, methodS in Patient-centered outcomes and HEalth ResEarch (SPHERE)-UMR 1246, F-37000 Tours, France.
诺 (FQs) 是有效的抗生素,但具有严重不良反应 (AE) 的风险,包括肌,中枢神经系统和心血管问题. 对风险因素和药物相互作用的认识可以帮助减轻这些与FQ相关的AE.
科学领域:
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
- 临床毒理学 临床毒理学
背景情况:
- 诺基诺 (FQs) 是具有显著临床功效的宽谱抗生素.
- 然而,FQs与一系列严重不良影响 (AE) 有关,需要仔细考虑.
研究的目的:
- 综合审查与诺基诺相关的频繁严重副作用的特征.
- 识别与FQ使用相关的风险因素,特定人群的安全概况和药物相互作用.
主要方法:
- 文献综述和现有关于诺基诺相关不良事件数据的综合.
- 报告病例的分析和详细介绍FQ毒性的临床研究.
主要成果:
- 常见的严重副作用包括肌疾病,中枢神经系统毒性,外围神经病变,心血管事件,葡萄糖失调,光毒性,C. difficile感染和器官毒性.
- 一些AE如肌病和神经病变可以在停止治疗后表现或随着时间的推移而进展.
- 风险因患者因素 (年龄,并发症),治疗特点 (剂量,持续时间) 和同时服用的药物而增加.
结论:
- 与许多用于类似指示的替代抗生素相比,诺基诺具有更高的严重副作用风险.
- 了解和管理诱导风险因素对于避免或最大限度地减少与FQ相关的不良事件至关重要.
相关概念视频
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Imaging Studies for Cardiovascular System III: X-Ray
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Radiological Investigation I: X-ray and CT
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...


